140 related articles for article (PubMed ID: 37409358)
1. Prolonged mucosal topical application of cyclosporin A for severe stomatitis of paraneoplastic pemphigus.
Hashimoto K; Kobayashi K; Nakamura Y; Yukino Y; Tsuji G; Kim H; Kataoka K; Amagai M
Australas J Dermatol; 2023 Aug; 64(3):439-441. PubMed ID: 37409358
[No Abstract] [Full Text] [Related]
2. Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: Treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin.
Namba C; Tohyama M; Hanakawa Y; Murakami M; Shirakata Y; Matsumoto T; Suemori K; Ishii N; Hashimoto T; Sayama K
J Dermatol; 2016 Apr; 43(4):419-22. PubMed ID: 26506947
[TBL] [Abstract][Full Text] [Related]
3. Topical tacrolimus (FK506) for relapsing erosive stomatitis in paraneoplastic pemphigus.
Vecchietti G; Kerl K; Hügli A; Samson J; Borradori L
Br J Dermatol; 2003 Apr; 148(4):833-4. PubMed ID: 12752158
[No Abstract] [Full Text] [Related]
4. Successful treatment of B cell chronic lymphocytic leukemia-associated severe paraneoplastic pemphigus with cyclosporin A.
Gergely L; Váróczy L; Vadász G; Remenyik E; Illés A
Acta Haematol; 2003; 109(4):202-5. PubMed ID: 12853695
[TBL] [Abstract][Full Text] [Related]
5. A Novel Use of Topical Ketamine for the Treatment of Oral Pemphigus: A Case Report.
Higgins EA; West JA
J Palliat Care; 2021 Jul; 36(3):146-147. PubMed ID: 32713289
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic Pemphigus. A Life-Threatening Autoimmune Blistering Disease.
Tirado-Sánchez A; Bonifaz A
Actas Dermosifiliogr; 2017 Dec; 108(10):902-910. PubMed ID: 28801011
[TBL] [Abstract][Full Text] [Related]
7. Successful immunomodulatory therapy in castleman disease with paraneoplastic pemphigus vulgaris.
Miltenyi Z; Toth J; Gonda A; Tar I; Remenyik E; Illes A
Pathol Oncol Res; 2009 Sep; 15(3):375-81. PubMed ID: 19067241
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic pemphigus: a refractory autoimmune mucocutaneous disease.
Ng PP; Rencic A; Nousari HC
J Cutan Med Surg; 2002; 6(5):434-7. PubMed ID: 12196890
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic pemphigus secondary to fludarabine evolving into unusual oral pemphigus vegetans.
Powell AM; Albert S; Oyama N; Sakuma-Oyama Y; Bhogal B; Black MM
J Eur Acad Dermatol Venereol; 2004 May; 18(3):360-4. PubMed ID: 15096157
[TBL] [Abstract][Full Text] [Related]
10. Recalcitrant paraneoplastic pemphigus associated with follicular dendritic cell sarcoma: response to prolonged rituximab and ciclosporin therapy.
Hwang YY; Chan JC; Trendell-Smith NJ; Kwong YL
Intern Med J; 2014 Nov; 44(11):1145-6. PubMed ID: 25367731
[No Abstract] [Full Text] [Related]
11. Paraneoplastic pemphigus associated with uterine carcinoma.
Niimi Y; Kawana S; Hashimoto T; Kusunoki T
J Am Acad Dermatol; 2003 May; 48(5 Suppl):S69-72. PubMed ID: 12734481
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic pemphigus treated with dexamethasone/ cyclophosphamide pulse therapy.
Becker LR; Bastian BC; Wesselmann U; Karl S; Hamm H; Bröcker EB
Eur J Dermatol; 1998 Dec; 8(8):551-3. PubMed ID: 9889426
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic pemphigus as the first manifestation of follicular dendritic cell sarcoma.
Liu KL; Shen JL; Yang CS; Chen YJ
J Dtsch Dermatol Ges; 2014 Jan; 12(1):68-71. PubMed ID: 24119156
[No Abstract] [Full Text] [Related]
14. Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).
Frew JW; Murrell DF
Dermatol Clin; 2011 Oct; 29(4):607-12. PubMed ID: 21925005
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic Pemphigus: Autoimmune-Cancer Nexus in the Skin.
Sinha AA
Anticancer Agents Med Chem; 2015; 15(10):1215-23. PubMed ID: 26179266
[TBL] [Abstract][Full Text] [Related]
16. [A case of follicular lymphoma complicated with lethal pemphigus].
Imataki O; Tamai Y; Abe Y; Ito I; Yoshikawa S; Kawakami K
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1677-80. PubMed ID: 17108741
[TBL] [Abstract][Full Text] [Related]
17. Systemic retinoid treatment in a case of hyperkeratotic lichenoid paraneoplastic pemphigus.
Yendo TM; Miyamoto D; Santi CG
Int J Dermatol; 2022 Feb; 61(2):231-233. PubMed ID: 34351632
[No Abstract] [Full Text] [Related]
18. Therapy of paraneoplastic pemphigus with Rituximab: A case report.
Zhang H; Hu B; Chen H; Wan L; Chen J; Zhou X; Chen L
Dermatol Ther; 2021 Nov; 34(6):e15144. PubMed ID: 34582076
[TBL] [Abstract][Full Text] [Related]
19. Successful use of intravenous and intralesional rituximab in paraneoplastic pemphigus with Castleman's disease.
Viswanath V; Tare D; Patil PC
Int J Dermatol; 2021 Sep; 60(9):e352-e354. PubMed ID: 33720390
[No Abstract] [Full Text] [Related]
20. Budesonide for local therapy of complex oral mucosal immune-mediated inflammatory diseases: case reports.
Utsman RA; Epstein JB; Elad S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):e11-7. PubMed ID: 18585605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
